Advances in the genetics of Parkinson disease. - Wikidata - wikimedia - TriplyDB

Advances in the genetics of Parkinson disease.

Advances in the genetics of Parkinson disease.

http://www.wikidata.org/entity/Q38121773

about

Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson's disease Genetic association of RIT2 rs12456492 polymorphism and Parkinson's disease susceptibility in Asian populations: a meta-analysis Oxidative stress and Parkinson's disease Mitochondrial dynamism and heart disease: changing shape and shaping change The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?Systems-Level G Protein-Coupled Receptor Therapy Across a Neurodegenerative Continuum by the GLP-1 Receptor System Upstream deregulation of calcium signaling in Parkinson's disease Potentiation of neurotoxicity in double-mutant mice with Pink1 ablation and A53T-SNCA overexpression.Diacylglycerol Kinases as Emerging Potential Drug Targets for a Variety of Diseases: An Update The EIF4G1 gene and Parkinson's disease Parkinson's disease genes VPS35 and EIF4G1 interact genetically and converge on α-synuclein Mitophagy mechanisms and role in human diseases Beyond mitophagy: cytosolic PINK1 as a messenger of mitochondrial health Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease The perplexing paradox of paraquat: the case for host-based susceptibility and postulated neurodegenerative effects Toxic Dopamine Metabolite DOPAL Forms an Unexpected Dicatechol Pyrrole Adduct with Lysines of α-Synuclein Neurotoxicity of the Parkinson Disease-Associated Pesticide Ziram Is Synuclein-Dependent in Zebrafish Embryos The RAB39B p.G192R mutation causes X-linked dominant Parkinson's disease Efficient Estimation of Nonparametric Genetic Risk Function with Censored Data.Copy number variability in Parkinson's disease: assembling the puzzle through a systems biology approach The neurobiological basis of cognitive impairment in Parkinson's disease.Holocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effects Behavioral Phenotyping and Pathological Indicators of Parkinson's Disease in C. elegans Models.High expression levels of the D686N Parkinson's disease mutation in VPS35 induces α-synuclein-dependent toxicity in yeast LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance.Systems-based analyses of brain regions functionally impacted in Parkinson's disease reveals underlying causal mechanisms RNA metabolism in the pathogenesis of Parkinson׳s disease An association study between Heme oxygenase-1 genetic variants and Parkinson's disease.The biology of proteostasis in aging and disease.Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease.Dysregulation of protein trafficking in neurodegeneration.Unbiased approaches to biomarker discovery in neurodegenerative diseases Glucocerebrosidase gene mutations associated with Parkinson's disease: a meta-analysis in a Chinese population Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and α-synuclein aggregation.Neuroprotective effects of porphyran derivatives against 6-hydroxydopamine-induced cytotoxicity is independent on mitochondria restoration.Prolongation of Chemically-Induced Methemoglobinemia in Mice Lacking α-synuclein: A Novel Pharmacologic and Toxicologic Phenotype.Parkinson's Disease in Saudi Patients: A Genetic Study Photobiomodulation Suppresses Alpha-Synuclein-Induced Toxicity in an AAV-Based Rat Genetic Model of Parkinson's Disease.Association study between SMPD1 p.L302P and sporadic Parkinson's disease in ethnic Chinese population

P2860

Q21131066-F0309316-1CDD-4785-8D09-9F454999B9A8 Q26782971-B7FF29AA-8F5B-44D8-AA69-7C2A316A3000 Q26786221-BB644731-DC1A-489E-A265-1B63F728D6F4 Q26798897-6E54833F-C8D5-4AA4-9723-36A700A18A75 Q26825299-EA452739-B187-486E-A05F-BA936113E4B8 Q26861263-D4DA749A-0CF9-4C12-8ECF-FE838FBF9758 Q26999386-F1DEDF6E-19D8-4F82-875E-2D32031A5073 Q27026384-83053608-90FB-4839-B8BD-829FC4F192C0 Q27301199-6B08750B-90CE-4E8C-90AA-9F102C945FBE Q28067133-7602A2C0-4034-472D-9910-912A804E964D Q28116373-34A8BE49-EAF9-46F8-B3A3-BCC33854FF36 Q28117589-1DAA7ABF-2B6C-4EF3-97E5-4580A3320A61 Q28390998-4661297B-0C3B-4223-82B3-01AF27D20FE6 Q28391455-730FC642-7D09-4C58-8524-A4727699A3A5 Q28391762-8A6B06A6-2E5B-4B72-B4F0-17FD31B0096E Q28396222-B61EF0A9-2ED2-4CD9-A19A-D21F35CC3670 Q28830423-6B97F87B-777B-4935-8F5F-DCBD0FDCDB97 Q29541727-DAA97A96-1D49-4991-89D6-6A0C0D99393F Q30665368-35528DAC-FEBF-4560-B0D9-F1BFAEAAFB8B Q30998396-F6B3A31A-D8B1-4F3D-B560-CBDB9BCE925F Q33364337-A2F837CD-39D9-4DF9-BCCE-CA418BE9638A Q33724698-CEA58E80-BFA8-47F7-81A7-37EACF1F6D67 Q33734084-6F2ACA04-D4BF-417A-BDC6-E71D08CCAB9E Q33790301-A2F3C103-DD57-4CBB-B5E5-8FDE70A00E01 Q33827945-2A808C24-0795-4E8A-9B04-CB67CCBA0F73 Q34079325-97FC07AF-B45D-42D4-8129-6BF0BC5A80EF Q34109658-7EAF8A89-AF29-46BA-86D9-D82C93DC40BE Q34175642-247B31A4-0110-4BAD-9C6A-3D95BA17AD6E Q34238382-50CB3592-39CA-44CD-922F-590E967EC253 Q34467650-3BF466FB-7BF1-4133-B00C-0F28BE0CCD36 Q34481921-4549ACF9-F025-48E3-87DC-7F0AEFE80EA8 Q34545170-AE98DD61-91BC-4AE2-9640-7911D36CEC3A Q34625918-64AA1AB3-0151-46E7-BA36-54F485FC78DE Q34764825-BD1B5648-1573-4632-99B6-AFAB6909ACEB Q35152964-20F46729-5FE2-4514-A252-B97E2B19A841 Q35169174-1525AF06-38EB-4FDA-B396-A5C1658BD07C Q35278967-D543E8CF-3879-4732-97F9-5BD52B25F559 Q35746162-DC287E8A-F169-4219-8BFC-8B838B48B06D Q35814444-1CFB216E-00A9-42AD-9025-9FAA3970F5A6 Q35835832-3AFEFBF3-5FF3-4EFA-B443-88F4CD9E6D24

P2860

Advances in the genetics of Parkinson disease.

http://www.wikidata.org/entity/Q38121773

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Advances in the genetics of Parkinson disease.

@en

type

label

Advances in the genetics of Parkinson disease.

@en

prefLabel

Advances in the genetics of Parkinson disease.

@en

P1433

Q38121773-3096AF2C-0E7C-4515-9EBC-3DED6116404A

P1476

Q38121773-2DE4C9A0-B3D9-4C62-833C-4C9843B362EB

P2093

Q38121773-FF4F0469-001D-4323-8D9F-DE3D0FA4D58F

P2860

Q38121773-005573F4-F0ED-4C34-B766-27C327894E2E

Q38121773-02B8C0EB-B6E4-442E-B45F-815CBFB69F33

Q38121773-05FC6EA1-9156-4168-AC27-78417C6715F4

Q38121773-06A27BE4-4922-47F7-BEDC-0093B6583D05

Q38121773-06D8D6A9-A356-4B68-AD8E-4CE2B483A895

Q38121773-0A6EE09B-134D-4CE7-A6AC-76A1D09247DC

Q38121773-0A95FABF-430D-4ED4-BEBD-66D4891208DA

Q38121773-0E9C1346-C419-434A-9A41-CC92EEE71088

Q38121773-0ECDB087-B739-49C8-AD78-55B5541DAE98

Q38121773-1001A7B9-44CD-4394-BC41-54C7AA85ADC4

P2888

Q38121773-7172DB80-FA51-49BA-91B3-14EF3929C2F6

P304

Q38121773-21666D88-5344-4FFC-8F19-68AE70A07502

P31

Q38121773-752A7F3A-261E-45CD-9233-48016CACA8AD

P356

Q38121773-EC7854F5-14D1-455D-8ED9-CE46F4D2C326

P407

Q38121773-47FB0240-0931-46CD-B886-DAF16EE0B9A0

P433

Q38121773-8D8CC0C2-2232-448C-BEC8-3E65731A5B35

P478

Q38121773-E3133FE7-39CB-4DF7-B0BA-8DE7981AF6F5

P50

Q38121773-168A6895-CF39-4451-8025-1F8EE391C842

P577

Q38121773-BAFB2549-AC1D-4E2A-AA1E-FF30A4A5D9B5

P5875

Q38121773-A1B23917-8D9E-451C-AD4B-46D7D81C9115

P6179

Q38121773-F380414C-90A3-425F-B6E6-822D95564978

P698

Q38121773-CFF9C2C8-9261-49D3-9A2B-2F44E1C45FE3

P921

Q38121773-E6925779-DE09-4D09-89D8-0F282840C3CC

P356

NRNEUROL.2013.132

P1433

Nature Reviews Neurology

P1476

Advances in the genetics of Parkinson disease.

@en

P2093

Joanne Trinh

http://www.w3.org/2001/XMLSchema#string

P2860

Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee

Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease

A deleterious mutation in DNAJC6 encoding the neuronal-specific clathrin-uncoating co-chaperone auxilin, is associated with juvenile parkinsonism

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism

Interplay of LRRK2 with chaperone-mediated autophagy

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease

P2888

nrneurol.2013.132

P304

445-454

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRNEUROL.2013.132

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Matthew J. Farrer

P577

2013-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

249868181

http://www.w3.org/2001/XMLSchema#string

P6179

1012629818

http://www.w3.org/2001/XMLSchema#string

P698

23857047

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease